Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study

NCT06094231 is registered in ClinicalTrials.gov with Department of Nephrology Clinic Ottakring Vienna as lead sponsor.

NCT NCT06094231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06094231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study
Lead sponsor
Department of Nephrology Clinic Ottakring Vienna
Phase
Not applicable
Overall status
Terminated
Start date
September 25, 2023
Completion date
April 13, 2026
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, diabetes mellitus, overweight and obesity, prediabetes